Bradsaúde (SAUD3) investor relations material

Executive summary

• Achieved 13.6 million members, with 99,000 net additions in health and 130,000 in dental in Q2 2026; SME segment surpassed 3 million beneficiaries.

• Revenue grew 11% year-over-year in 2Q26 to R$13.9 billion and 10% in 1H26 to R$27.3 billion; net income rose 25% in 2Q26 to R$1.1 billion and 28% in 1H26 to R$2.4 billion.

• ROE/ROAE increased by four percentage points to 25.8% in the period.

• Atlântica Hospitais' net income surged 312% to R$64 million, now representing 6% of consolidated results.

• Corporate reorganization completed in May 2026, with Bradsaúde shares trading under ticker SAUD3.

Financial highlights

• Consolidated revenue for the last 12 months reached BRL 54 billion, up from BRL 52 billion at the end of February.

• Net income for 2Q26 reached R$1.1 billion, a 24.8% increase from R$0.9 billion in 2Q25; 1H26 net income was R$2.4 billion (+27.6% YoY).

• Bradesco Saúde premiums grew at an average annual rate of over 12% since 2022, reaching BRL 13 billion.

• Odontoprev revenue reached BRL 2.5 billion, with net margin over 20% per year.

• Financial assets reached R$29.6 billion (+8.7% YoY).

Outlook and guidance

• Management expects continued stability in the loss ratio for the remainder of 2026, with some seasonality in Q3 but overall relative stability for the year.

• Growth strategy focuses on disciplined underwriting, SME segment expansion, and maintaining profitability.

• Expansion in hospital network and continued focus on SME and corporate segments expected to drive future growth.

• Atlântica Hospitais expected to increase its share of consolidated results to over 10% in five to seven years.

• Continued expansion in hospital bed capacity projected through 2030, supporting long-term growth.